Skip to content

Clinical trials

Liver Cirrhosis, Biliary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20051
20062
20073
20081
20091
20102
20113
20121
20132
20145
20155
20163
20178
20184
20192
20203
20214
20228
20233
20247
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated14
Recruiting8
Active, not recruiting7
Withdrawn3
Not yet recruiting1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intercept Pharmaceuticals10
Gilead Sciences9
Ipsen6
Mayo Clinic6
Zydus Therapeutics Inc.6
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
GlaxoSmithKline3
Mirum Pharmaceuticals, Inc.3
Kowa Research Institute, Inc.2
NGM Biopharmaceuticals, Inc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary82
Fibrosis8
Pruritus8
Cholangitis, Sclerosing6
Cholestasis4
Cholangitis3
Fatigue3
Hepatitis, Autoimmune3
Liver Diseases3
Rare Diseases3

Trials

Showing 26 to 50 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.